ArticleBiomedicines2022

A Novel 16-Genes Signature Scoring System as Prognostic Model to Evaluate Survival Risk in Patients with Glioblastoma.

Zunpeng Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.